Leukemia Derived Dendritic Cells (LDCs) Are Functionally Deficient and Inferior to DC/Leukemia Fusion Cells as a Tumor Vaccine for AML.Jacalyn Rosenblatt, David Avigan, Richard M. Stone et al.|Blood|2005Cited by 0
Targeting MUC1 as a Marker for Myeloid Leukemia Stem Cells by DC/AML Fusions.Jacalyn Rosenblatt, David Avigan, Zekui Wu et al.|Blood|2007Cited by 0
Length of mediports use in patients treated with curative intent.Aman Opneja, Kenneth Miller, Prashant Tripathi et al.|Journal of Clinical Oncology|2015Cited by 0
Oncologists' opinions about second opinions in cancer care.Kenneth Miller, Prashant Tripathi, Aman Opneja|Journal of Clinical Oncology|2015Cited by 0